Association of Anticoagulant Therapy with Risk of Fracture among Patients with Atrial Fibrillation

Keyphrases

• Warfarin 100%
• Atrial Fibrillation 100%
• Fracture Risk 100%
• Anticoagulant Therapy 100%
• Hazard Ratio 60%
• Hip Fracture 40%
• Apixaban 30%
• Hospitalization 30%
• Clinical Fractures 30%
• Osteoporosis Diagnosis 30%
• Low Risk 20%
• Bone Health 20%
• New User 20%
• Non-valvular Atrial Fibrillation 20%
• Comparative Safety 10%
• Diabetes 10%
• Hypertension 10%
• High Risk 10%
• Comparative Effectiveness 10%
• Congestive Heart Failure 10%
• Dabigatran Etexilate 10%
• Oral Anticoagulants 10%
• Real-world Population 10%
• Vascular Disease 10%
• Subgroup Analysis 10%
• Rivaroxaban 10%
• Multivariable 10%
• Direct Oral Anticoagulants 10%
• Propensity Score Matching 10%
• International Classification of Diseases 10%
• Total Fracture 10%
• Confounding 10%
• Disease Score 10%
• Potential Adverse Effects 10%
• Transient Ischemic Attack 10%
• Administrative Claims Database 10%
• Ninth Revision 10%
• MarketScan 10%
• Clinical Modification 10%
• Previous Stroke 10%
• High-dimensional Propensity Score 10%
• Cardioembolic Complications 10%
• Incident Fractures 10%
• Cox Proportional Hazards Regression Model 10%
• CHA2DS2-VASc 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Anticoagulant Agent 100%
• Warfarin 100%
• Atrial Fibrillation 100%
• Hip Fracture 40%
• Apixaban 30%
• Cohort Study 10%
• Direct Oral Anticoagulant 10%
• Population Study 10%
• Dabigatran Etexilate 10%
• Cerebrovascular Accident 10%
• Rivaroxaban 10%
• Adverse Event 10%
• Transient Ischemic Attack 10%
• Congestive Heart Failure 10%
• International Classification of Diseases 10%
• Vascular Disease 10%